|
|
Filed
by Genus, Inc. Pursuant to Rule 425 |
|
|
Under
the Securities Act of 1933 |
|
|
Subject
Company: Genus, Inc. |
|
|
Commission
File No.: 000-17139 |
|
|
|
The
following press release was issued by Genus, Inc. on March 8,
2005. |
|
|
|
Editorial
Contact: |
|
Genus
Contact: |
Trine
Pierik |
|
Shum
Mukherjee |
Positio
Public Relations, Inc. |
|
Genus,
Inc |
Tel:
(408) 453-2400 |
|
Tel:
(408) 747-7140 |
Email:
trine@positio.com |
|
Email:
smukherjee@genus.com |
AIXTRON
and Genus to Waive Condition Precedent to Merger for
Quotation
on Nasdaq National Market
SUNNYVALE,
Calif.-March 8, 2005- Genus,
Inc. (NASDAQ : GGNS), announced today that the bid price for AIXTRON ADSs may
not initially meet the minimum bid price required for quotation on the Nasdaq
National Market. Accordingly, AIXTRON and Genus
currently intend to waive their respective conditions precedent to effect the
previously announced merger between the companies, which required AIXTRON’s ADSs
to have been approved for quotation on the Nasdaq National Market prior to the
effective time of the merger.
AIXTRON’s
obligation to use all reasonable efforts to cause AIXTRON’s ADSs
issued in the merger to be quoted on the Nasdaq National Market from and after
the effective time until 18 months after the effective time would not be
affected by this waiver.
About
Genus, Inc.
Genus,
Inc. manufactures critical deposition processing products for the global
semiconductor industry and the data storage industry. To enable the production
of intricate micro-computer chips and electronic storage devices, Genus offers
its LYNX and
StrataGem series
of production-proven equipment for 200 mm and 300 mm semiconductor production,
and offers thin film deposition products for chemical vapor deposition (CVD),
atomic layer deposition (ALD), and wafer pre-clean capabilities. Genus is at the
forefront of market and technology developments in the ALD marketplace, which is
gaining acceptance worldwide as a critical technology for sub-0.13-micron
production of computer chips and electronic storage devices. Genus' customers
include semiconductor manufacturers located throughout the United States, Europe
and the Pacific Rim including Korea, Japan and Taiwan. Founded in 1981, the
company is headquartered in Sunnyvale, Calif. For additional information visit
Genus' web site at www.genus.com.
NOTE:
LYNX2®, and
LYNX3™ are
trademarks of Genus, Inc.
Additional
Information
AIXTRON
and Genus entered into a definitive merger agreement on July 1, 2004. AIXTRON
has filed a registration statement on Form F-4 with the US Securities and
Exchange Commission, or SEC, which includes a prospectus of AIXTRON and a proxy
statement of Genus. Investors and security holders are urged to read the proxy
statement/prospectus regarding the business combination transaction referenced
in the foregoing information because it will contain important information.
Investors and security holders may obtain a free copy of the proxy
statement/prospectus and other documents filed by AIXTRON and Genus with the SEC
at the SEC's website at www.sec.gov. The proxy statement/prospectus and these
other documents may also be obtained for free from AIXTRON by directing a
request to AIXTRON Investor Relations at Kackertstr.15-17, 52072 Aachen, +49 241
8909 444 or from Genus, by directing a request to Genus Investor Relations at
1139 Karlstad Drive, Sunnyvale, Calif. 94089, (408) 747-7140 Ext. 1311.
Certain
Participants
AIXTRON
and its directors and executive officers may be deemed to be participants in the
solicitation of proxies from the shareholders of Genus in connection with the
merger. Information regarding the special interests of these directors and
executive officers in the merger will be included in the proxy
statement/prospectus described above. Genus and its directors and executive
officers may be deemed to be participants in the solicitation of proxies from
the shareholders of Genus in connection with the merger. Information regarding
the special interests of these directors and executive officers in the merger
will be included in the proxy statement/prospectus described above.
# #
#